Axsome Therapeutics, Inc. (AXSM)
162.33
+0.87
(+0.54%)
USD |
NASDAQ |
Mar 06, 16:00
162.33
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics SG&A Expense (TTM) : 570.60M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 448.72M |
| Vanda Pharmaceuticals, Inc. | 237.95M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Amicus Therapeutics, Inc. | 383.49M |
| Insmed, Inc. | 701.17M |